EUVIMEDEUVIMED entdecken
Crossref

The Economics of the Public Option: Evidence from Local Pharmaceutical Markets

Juan Pablo Atal, José Ignacio Cuesta, Felipe González, Cristóbal Otero

American Economic Review · 01.03.2024 · 114 (3) · 615-644

DOI: 10.1257/aer.20211547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Economic Review, erschienen am 01.03.2024. Verfasst von Juan Pablo Atal und 3 weiteren Autor:innen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 82 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, which benefited the switchers to the public option but harmed the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent. (JEL D22, I18, L32, L65, O14)

Zitieren

APA

Atal, J. P., Cuesta, J. I., González, F., & Otero, C. (2024). The Economics of the Public Option: Evidence from Local Pharmaceutical Markets. American Economic Review, 114(3), 615-644. https://doi.org/10.1257/aer.20211547

Vancouver

Atal JP, Cuesta JI, González F, Otero C. The Economics of the Public Option: Evidence from Local Pharmaceutical Markets. American Economic Review. 2024;114(3):615-644. doi:10.1257/aer.20211547

BibTeX
@article{Atal2024,
  author = {Atal, Juan Pablo and Cuesta, José Ignacio and González, Felipe and Otero, Cristóbal},
  title = {The Economics of the Public Option: Evidence from Local Pharmaceutical Markets},
  journal = {American Economic Review},
  year = {2024},
  volume = {114},
  number = {3},
  pages = {615--644},
  doi = {10.1257/aer.20211547}
}
Kostenlos starten →